Stock Screener App

무료 -

1.28

2.40% +0.03

TRACON Pharmaceuticals Inc (TCON)

개요 뉴스 가격 이력 옵션 체인 Financials 토론 예측 주식 분할

TRACON Pharmaceuticals Inc 주식(TCON)의 최신 뉴스

In the Green: TRACON Pharmaceuticals Inc (TCON) Closes at 1.25, Up/Down -17.22 from Previous Day – DWinneX - The Dwinnex

TRACON Pharmaceuticals (NASDAQ:TCON) Stock Price Passes Below 50 Day Moving Average of $3.55 - Defense World

Tracon: 2Q Earnings Snapshot - Yahoo News UK

TRACON Pharmaceuticals (NASDAQ:TCON) Rating Lowered to Hold at StockNews.com - Defense World

TRACON Pharmaceuticals (NASDAQ:TCON) Rating Lowered to Hold at StockNews.com - Defense World

David Lazar Joins TRACON Pharmaceuticals as Chief Business Officer - TipRanks.com - TipRanks

TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Q1 2024 Earnings Call Transcript - Insider Monkey

TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Q1 2024 Earnings Call Transcript - Insider Monkey

TRACON Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewswire

TRACON Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update - Yahoo Finance

TRACON Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update - Yahoo Finance

David Lazar Joins TRACON Pharmaceuticals as Chief Business Officer - TipRanks.com - TipRanks

TRACON Pharmaceuticals (NASDAQ:TCON) Stock Rating Lowered by StockNews.com - Defense World

TRACON Pharmaceuticals (NASDAQ:TCON) Stock Rating Lowered by StockNews.com - Defense World

TRACON Pharmaceuticals (TCON) to Release Earnings on Tuesday - Defense World

Shareholders Should Check The Ownership Structure Of TRACON Pharmaceuticals Inc (NASDAQ:TCON) - Yahoo Movies Canada

Yahoo Movies Canada

TRACON to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024 - Yahoo Canada Finance

Yahoo Canada Finance

TRACON to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024 - Yahoo Finance

TRACON Pharmaceuticals (NASDAQ:TCON) Stock Price Crosses Below Two Hundred Day Moving Average of $4.04 - Defense World

Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Why Medical Properties Trust Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket

Why Medical Properties Trust Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Markets Insider

Markets Insider

UTHR: 3 Promising Biotech Stocks Driving Weekly Gains - StockNews.com

Wall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for April 2024 - InvestorPlace

Wall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for April 2024 - InvestorPlace

Why Agenus Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Monday's Mid-Day Session

TRACON Pharmaceuticals Announces Reverse Stock Split

GlobeNewswire Inc.

Shares of Tracon Pharmaceuticals Tumble 22% on Reverse Split - MarketWatch

Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Tracon stock drops on data for cancer drug (NASDAQ:TCON) - Seeking Alpha

Why VirTra Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket

Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid ... - Markets Insider

Markets Insider

StockNews.com Begins Coverage on TRACON Pharmaceuticals (NASDAQ:TCON) - American Banking and Market News

American Banking and Market News

TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Q4 2023 Earnings Call Transcript - Yahoo Finance

TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update

GlobeNewswire Inc.

TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update - Yahoo Finance

TRACON to Report Fourth Quarter and Year-End 2023 Financial Results and Provide Corporate Update on March 5, 2024

GlobeNewswire Inc.

TRACON to Report Fourth Quarter and Year-End 2023 Financial Results and Provide Corporate Update on March 5 ... - GlobeNewswire

TRACON Pharmaceuticals Provides Positive Update on Ongoing ENVASARC Pivotal Phase 2 Trial - Yahoo Finance

Tracon Pharma (NASDAQ: TCON) up 58% - it might, actually, have something to sell - Dhaka Tribune

TRACON Pharmaceuticals Announces License of Product Development Platform for $3.0 Million Upfront Payment - GlobeNewswire

Why Is Tracon Pharmaceuticals (TCON) Stock Down 22% Today? - InvestorPlace

TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Q3 2023 Earnings Call Transcript - Yahoo Finance

Why Is Tracon Pharmaceuticals (TCON) Stock Up 130% Today? - InvestorPlace

TRACON Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update - GlobeNewswire

Tracon Pharmaceuticals Shares Drop After Arbitration Award in I-Mab Dispute - Marketscreener.com

Marketscreener.com

TRACON Pharmaceuticals Announces ENVASARC Phase 2 Pivotal Trial Exceeded Futility Threshold at Final Interim ... - Yahoo Finance

7 F-Rated Biotech Stocks You Shouldn't Touch With a 10-Foot Pole - InvestorPlace

$75.07

0.79%

$148.85

3.50%

$28.20

0.75%

$148.43

1.07%

$371.02

2.45%

$100.60

1.87%

야후에서 열기 | 구글에서 열기 | 핀비즈에서 열기